Factors associated with dose escalation or cessation of vedolizumab in patients with inflammatory bowel disease
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 18 Jan 2018 New trial record